Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart pump trial offers hope for shock patients

NCT ID NCT07293923

First seen Jan 06, 2026 · Last updated May 20, 2026 · Updated 21 times

Summary

This study tests a temporary heart pump (Magenta Elevate) in 10 people with cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. The pump is inserted through the skin to help the left ventricle work better. The goal is to see if it's safe and can quickly improve blood pressure and stability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Israeli-Georgian Medical Research Clinic Helsicore

    RECRUITING

    Tbilisi, Georgia

    Contact

  • Rambam Medical Center

    RECRUITING

    Haifa, Israel

    Contact

  • Shamir Medical Center

    RECRUITING

    Be’er Ya‘aqov, Israel

    Contact

  • Tbilisi Heart Center

    RECRUITING

    Tbilisi, Georgia

    Contact

  • Tel-Aviv Sourasky Medical Center

    RECRUITING

    Tel Aviv, Israel

    Contact

Conditions

Explore the condition pages connected to this study.